Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram (Q34645756)

3 August 2017

0 references

Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram (English)

1 reference

3 August 2017

Brian J Piper

1

1 reference

3 August 2017

Joseph B Fraiman

2

1 reference

3 August 2017

Cullen B Owens

3

1 reference

3 August 2017

Syed F Ali

4

1 reference

3 August 2017

Jerrold S Meyer

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

4 July 2007

1 reference

3 August 2017

published in

Neuropsychopharmacology

1 reference

3 August 2017

volume

33

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

1192-1205

1 reference

MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Neuroimaging research in human MDMA users: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Empathy and aggression: two faces of ecstasy? A study of interpretative cognitive bias and mood change in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Can social interaction be used to measure anxiety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Long-lasting effects of chronic chlorimipramine treatment of rats on exploratory activity on a hole-board, and on immobility in the forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Hypothalamic–pituitary–adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine (‘ecstasy’) use history: correlation with dopamine receptor sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Habituation in rodents: a review of behavior, neurobiology, and genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

An automated method for studying exploratory and stereotyped behaviour in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Amphetamine neurotoxicity: accomplishments and remaining challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Serotonin, locomotion, exploration, and place recall in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

(+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Repeated MDMA ("Ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Effects of SSRIs on sexual function: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Novelty seeking behavior in the rat is dependent upon the integrity of the noradrenergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

The "ecstasy" hangover: hyponatremia due to 3,4-methylenedioxymethamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

(+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Development of acute withdrawal during periodic administration of amphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

An activity indicator of acute withdrawal depends on amphetamine dose in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Evidence for an involvement of peripheral serotonin in p-chloroamphetamine-induced ejaculation of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

7 January 2021

Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

7 January 2021

Repeated trials with the albino rat in the open field as a function of age and deprivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

7 January 2021

Violence and serotonin: influence of impulse control, affect regulation, and social functioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

7 January 2021

Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

7 January 2021

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

7 January 2021

Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

7 January 2021

Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

7 January 2021

Repeated administration of MDMA down-regulates preprocholecystokinin mRNA expression but not tyrosine hydroxylase mRNA expression in neurones of the rat substantia nigra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301491

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301491

1 reference

Dimensions Publication ID

3 August 2017

1039974901

0 references

1 reference